Salinomycin alleviates osteoarthritis progression via inhibiting Wnt/β-catenin signaling
Year: 2022
Type: article
Source: International Immunopharmacology
Authors: Jian Chen, Jia Liu, Shimin Chen, Ruijun Lai, Chuanchuan Zheng, Jialiang Lu, Xinshao Jiang, Feng He, Chengliang Yang, Kai Li, Kegong Xie, Yujin Tang, Liqiang Wang
Institutions: Youjiang Medical College for Nationalities, Affiliated Hospital of Youjiang Medical University for Nationalities, The First People's Hospital of Zhaoqing, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Guangxi Medicinal Botanical Garden, Southern Medical University, Third Affiliated Hospital of Southern Medical University, Shanghai Jiao Tong University, State Key Laboratory of Metal Matrix Composites
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: salinomycin, osteoarthritis, Wnt/β-catenin signaling, LRP6 phosphorylation, chondrocytes, cartilage degeneration, extracellular matrix degradation, MMP-13, ADAMTS5, type II collagen, aggrecan, IL-1β, subchondral sclerosis, osteophyte formation, disease-modifying therapy, polyether ionophores
Open Access status: closed
OpenAlex ID: W4295421034
